Modelling the cost-effectiveness of HIV care shows a clear benefit when transmission risk is considered in the calculations – A message for Central and Eastern EuropeJustyna Kowalska(Medical University of Warsaw), Ewa SiewaszewiczPLoS ONENovember 13, 201710.1371/journal.pone.0186131Cited by 13SaveCiteExport RISWatch citationsRelated PapersThe Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center|Vaccines|2022|26